Showing results (491-500 of 7,393) with videos related to

Sort By:
Pageof 740
Allergy|September 5, 2025
Omics in NSAID-Exacerbated Respiratory Disease: Current Evidence From the Upper and Lower AirwaysAleksandr iAkushev, Piotr Szatkowski, Maria Vorobeva, et al.
Allergy|January 1, 1985
Antibodies in allergy and inflammation. Research tools and indicators of diseaseL Yman
Allergy|August 30, 2025
Two-Year Turning Point With Dupilumab in CRSwNP: Control, Remission, and Tapering DosageEugenio De Corso, Claudio Montuori, Carlotta Pipolo, et al.
Allergy|May 29, 2015
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrateB L Zuraw, M Cicardi, H J Longhurst, et al.
Allergy|May 27, 2015
Exposure to grass pollen--but not birch pollen--affects lung function in Swedish childrenO Gruzieva, G Pershagen, M Wickman, et al.
Allergy|May 11, 2021
Innovative robust basophil activation test using a novel gating strategy reliably diagnosing allergy with full automationJochen Behrends, Christian Schwager, Martina Hein, et al.
Allergy|May 12, 2021
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposisGiorgio Walter Canonica, Tim W Harrison, Pascal Chanez, et al.
Allergy|June 5, 2020
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factorsUrszula Radzikowska, Mei Ding, Ge Tan, et al.
Allergy|June 10, 2020
ST2 expression and release by the bronchial epithelium is downregulated in asthmaDavinder Kaur, Latifa Chachi, Edith Gomez, et al.
Allergy|May 16, 2021
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVIDMatthew Plassmeyer, Oral Alpan, Michael J Corley, et al.
Pageof 740